This week in gene and cell therapy - 4 January 2019

Gene and cell therapy headlines 31 December - 4 January

Gene therapy for retinal disease choroideremia safe and effective

Arbor Biotechnologies and Vertex Pharmaceuticals to partner for the development of gene therapies for CF and other diseases

Celgene purchased by Bristol-Myers-Squibb

Takeda expands into immuno-oncology cell therapies